ArticleCellular oncology (Dordrecht, Netherlands)2025

Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma.

Jiajun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.